SAN FRANCISCO--(BUSINESS WIRE)--In a presentation to investors today at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco, Biogen Idec (NASDAQ: BIIB) Chief Executive Officer James C. Mullen will outline the company’s plan to continue to drive shareholder value. Mr. Mullen speaks at 4:30 p.m. PST today, and his remarks will be available via webcast on the Investor Relations section of www.biogenidec.com. A corresponding slide presentation will also be available on the website.
